Literature DB >> 21977115

Perioperative management of patients with lung carcinoma and cerebral metastases.

Eva Gheorghita1, Viorel Mihai Pruna, Luminita Neagoe, Cristina Bucur, Catioara Cristescu, Mircea Radu Gorgan.   

Abstract

OBJECTIVE: The present study proposes to present the importance of perioperative therapeutic management in survival prolongation and the quality of life for patients that have undergone surgery for cerebral metastases secondary to pulmonary tumors.
METHOD: During 2001-2009, 40 patients with ages between 43-74 years have been diagnosed in our clinic with pulmonary tumor and cerebral metastases. The patients presented single cerebral lesion (excepting one patient with 2 cerebral metastases) and pulmonary tumor. Intracranial pressure (ICP) was high in all cases. All patients have undergone operation with general anesthesia.
RESULTS: For all patients the reduction of ICP and keeping an optimal CPP (cerebral perfusion pressure) was pursued. In 38 cases, general anesthesia was performed with Sevoflurane and opioids (fentanyl, remifentanyl, sufentanyl) and in 2 cases the TIVA (total intravenous anesthesia) technique was used with propofol and remifentanyl. 14 of the patients required intraoperative depletive treatment through administering mannitol 20%. 37 patients (92%) have been discharged with improved neurological condition without showing signs of intracranial hypertension, convulsive seizures and with partially or totally remitted hemiparesis and one patient had worse postoperative neurological status.
CONCLUSION: Pulmonary tumor with cerebral metastases represent an important cause for death rate. To solve secondary cerebral lesions, the perioperative management must include assesment and choosing an anesthesia technique with a proper intraoperative management.

Entities:  

Keywords:  cerebral edema; cerebral metastases; lung cancer; surgery

Year:  2010        PMID: 21977115      PMCID: PMC3150086     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  22 in total

Review 1.  The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review.

Authors:  L C Marras; W H Geerts; J R Perry
Journal:  Cancer       Date:  2000-08-01       Impact factor: 6.860

2.  USE OF GLUCOCORTICOIDS IN THE PALLIATIVE TREATMENT OF METASTATIC BRAIN TUMORS.

Authors:  N B RUDERMAN; T C HALL
Journal:  Cancer       Date:  1965-03       Impact factor: 6.860

3.  The management of metastases to the brain by irradiation and corticosteroids.

Authors:  J Horton; D H Baxter; K B Olson
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1971-02

4.  EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force.

Authors:  R Soffietti; P Cornu; J Y Delattre; R Grant; F Graus; W Grisold; J Heimans; J Hildebrand; P Hoskin; M Kalljo; P Krauseneck; C Marosi; T Siegal; C Vecht
Journal:  Eur J Neurol       Date:  2006-07       Impact factor: 6.089

5.  Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day.

Authors:  C J Vecht; A Hovestadt; H B Verbiest; J J van Vliet; W L van Putten
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

Review 6.  Thromboembolism in brain tumors.

Authors:  D C Walsh; A K Kakkar
Journal:  Curr Opin Pulm Med       Date:  2001-09       Impact factor: 3.155

7.  Resection for solitary brain metastasis. Role of adjuvant radiation and prognostic variables in 229 patients.

Authors:  S R Smalley; E R Laws; J R O'Fallon; E G Shaw; M F Schray
Journal:  J Neurosurg       Date:  1992-10       Impact factor: 5.115

Review 8.  Some inquiries in neuroanesthesia and neurological supportive care.

Authors:  E A Frost
Journal:  J Neurosurg       Date:  1984-04       Impact factor: 5.115

9.  Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy.

Authors:  H O Conn; T Poynard
Journal:  J Intern Med       Date:  1994-12       Impact factor: 8.989

10.  Treatment for patients with cerebral metastases.

Authors:  W R Markesbery; W H Brooks; G D Gupta; A B Young
Journal:  Arch Neurol       Date:  1978-11
View more
  1 in total

1.  Propofol suppresses the progression of non‑small cell lung cancer via downregulation of the miR‑21‑5p/MAPK10 axis.

Authors:  Xinhua Wu; Xuebin Li; Guiping Xu
Journal:  Oncol Rep       Date:  2020-05-21       Impact factor: 3.906

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.